{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:49:30Z","timestamp":1790293770288,"version":"4.1.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1038\/s41440-024-01896-0","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T07:02:52Z","timestamp":1726729372000},"page":"244-255","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Current use of angiotensin II receptor blockers and angiotensin-converting enzyme inhibitors for hypertension in patients with chronic kidney disease with proteinuria: a cross-sectional study based on real-world data"],"prefix":"10.1038","volume":"48","author":[{"given":"Kazuhiro","family":"Tada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Hiyamuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maho","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuhiko","family":"Yasuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Kawazoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikara","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masutani","family":"Kosuke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisatomi","family":"Arima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,19]]},"reference":[{"key":"1896_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jash.2014.10.008","volume":"9","author":"JW Lohr","year":"2015","unstructured":"Lohr JW, Golzy M, Carter RL, Arora P. Elevated systolic blood pressure is associated with increased incidence of chronic kidney disease but not mortality in elderly veterans. J Am Soc Hypertens. 2015;9:29\u201337.","journal-title":"J Am Soc Hypertens"},{"key":"1896_CR2","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.2215\/CJN.00180115","volume":"10","author":"LA Inker","year":"2015","unstructured":"Inker LA, Tighiouart H, Aspelund T, Gudnason V, Harris T, Indridason OS, et al. Lifetime risk of stage 3-5 CKD in a community-based sample in Iceland. Clin J Am Soc Nephrol. 2015;10:1575\u201384.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1896_CR3","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1093\/ajh\/hpv003","volume":"28","author":"A Hirayama","year":"2015","unstructured":"Hirayama A, Konta T, Kamei K, Suzuki K, Ichikawa K, Fujimoto S, et al. Blood pressure, proteinuria, and renal function decline: associations in a large community-based population. Am J Hypertens. 2015;28:1150\u20136.","journal-title":"Am J Hypertens"},{"key":"1896_CR4","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1001\/jama.285.21.2719","volume":"285","author":"LY Agodoa","year":"2001","unstructured":"Agodoa LY, Appel L, Bakris GL, Beck G, Bourgoignie J, Briggs JP, et al. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA. 2001;285:2719\u201328.","journal-title":"JAMA"},{"key":"1896_CR5","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/hr.2009.44","volume":"32","author":"T Saruta","year":"2009","unstructured":"Saruta T, Hayashi K, Ogihara T, Nakao K, Fukui T, Fukiyama K, et al. Effects of candesartan and amlodipine on cardiovascular events in hypertensive patients with chronic kidney disease: subanalysis of the CASE-J Study. Hypertens Res. 2009;32:505\u201312.","journal-title":"Hypertens Res"},{"key":"1896_CR6","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","volume":"42","author":"S Umemura","year":"2019","unstructured":"Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res. 2019;42:1235\u2013481.","journal-title":"Hypertens Res"},{"key":"1896_CR7","unstructured":"Japanese Society of Nephrology. Evidence-based Clinical Practice Guidelines for Chronic Kidney Disease 2018. Tokyo, Japan: Tokyo Igakusha; 2018."},{"key":"1896_CR8","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1080\/10641963.2021.2022688","volume":"44","author":"R Yang","year":"2022","unstructured":"Yang R, Tang J, Zhuo Y, Kuang M, Liu H. Current prescription status of antihypertensive drugs in Chinese patients with hypertension: analysis by type of comorbidities. Clin Exp Hypertens. 2022;44:240\u20138.","journal-title":"Clin Exp Hypertens"},{"key":"1896_CR9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/10641963.2018.1465074","volume":"41","author":"T Ishida","year":"2019","unstructured":"Ishida T, Oh A, Hiroi S, Shimasaki Y, Tsuchihashi T. Current prescription status of antihypertensive drugs in Japanese patients with hypertension: Analysis by type of comorbidities. Clin Exp Hypertens. 2019;41:203\u201310.","journal-title":"Clin Exp Hypertens"},{"key":"1896_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ki.2010.483","volume":"80","author":"AS Levey","year":"2011","unstructured":"Levey AS, De Jong PE, Coresh J, El NM, Astor BC, Matsushita K, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011;80:17\u201328.","journal-title":"Kidney Int"},{"key":"1896_CR11","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1253\/circj.66.987","volume":"66","author":"Examination Committee","year":"2002","unstructured":"Examination Committee. of Criteria for \u2018Obesity Disease\u2019 in Japan; Japan Society for the Study of Obesity. New criteria for \u2018obesity disease\u2019 in Japan. Circ J. 2002;66:987\u201392.","journal-title":"Circ J"},{"key":"1896_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s13340-020-00439-5","volume":"11","author":"E Araki","year":"2020","unstructured":"Araki E, Goto A, Kondo T, Noda M, Noto H, Origasa H, et al. Japanese Clinical Practice Guideline for Diabetes 2019. Diabetol Int. 2020;11:165\u2013223.","journal-title":"Diabetol Int"},{"key":"1896_CR13","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/s41440-018-0116-3","volume":"42","author":"E Mishima","year":"2019","unstructured":"Mishima E, Haruna Y, Arima H. Renin-angiotensin system inhibitors in hypertensive adults with non-diabetic CKD with or without proteinuria: a systematic review and meta-analysis of randomized trials. Hypertens Res. 2019;42:469\u201382.","journal-title":"Hypertens Res"},{"key":"1896_CR14","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2020.11.003","volume":"99","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group.","year":"2021","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int. 2021;99:S1\u201387.","journal-title":"Kidney Int"},{"key":"1896_CR15","unstructured":"Japanese Society of Nephrology. Evidence-based Clinical Practice Guidelines for Chronic Kidney Disease 2023. Tokyo, Japan: Tokyo Igakusha; 2023."},{"key":"1896_CR16","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/s41440-019-0238-2","volume":"42","author":"M Ohishi","year":"2019","unstructured":"Ohishi M, Yoshida T, Oh A, Hiroi S, Takeshima T, Otsuka Y, et al. Analysis of antihypertensive treatment using real-world Japanese data-the retrospective study of antihypertensives for lowering blood pressure (REAL) study. Hypertens Res. 2019;42:1057\u201367.","journal-title":"Hypertens Res"},{"key":"1896_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.990997","volume":"10","author":"F Li","year":"2023","unstructured":"Li F, Sun A, Wu F, Zhang D, Zhao Z. Trends in using of antihypertensive medication among US CKD adults, NHANES 2001-2018. Front Cardiovasc Med. 2023;10:990997. https:\/\/doi.org\/10.3389\/fcvm.2023.990997","journal-title":"Front Cardiovasc Med"},{"key":"1896_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-55827-7","volume":"14","author":"T Tanaka","year":"2024","unstructured":"Tanaka T, Maruyama S, Chishima N, Akiyama H, Shimamoto K, Inokuchi S, et al. Population characteristics and diagnosis rate of chronic kidney disease by eGFR and proteinuria in Japanese clinical practice: an observational database study. Sci Rep. 2024;14:5172.","journal-title":"Sci Rep"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01896-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01896-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01896-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T04:36:11Z","timestamp":1736138171000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01896-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,19]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["1896"],"URL":"https:\/\/doi.org\/10.1038\/s41440-024-01896-0","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,19]]},"assertion":[{"value":"30 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}